Related Experiment Video
Updated: Oct 20, 2025
08:50
Scalable Biomanufacturing Workflow to Produce and Isolate Natural Killer Cell-Derived Extracellular Vesicle-Based Cancer Biotherapeutics
Published on: August 16, 2024
969
Therapeutic Potential of Nucleic Acids when Combined with Extracellular Vesicles
Brian Jurgielewicz1,2, Steven Stice1,2,3, Yao Yao1,2
11Regenerative Bioscience Center, University of Georgia, Athens, GA 30602, USA.
Aging and Disease
|September 16, 2021
Summary
Extracellular vesicles (EVs) are natural nanocarriers being developed for nucleic acid therapies. Their low immunogenicity and ability to target cells make them promising delivery vectors for genetic disorders.
Area of Science:
- Biotechnology
- Nanomedicine
- Molecular Biology
Background:
- Extracellular vesicles (EVs) are natural nanocarriers involved in intercellular communication.
- EVs deliver proteins, lipids, and genetic material, modulating recipient cell functions.
- Their inherent properties offer advantages for therapeutic applications.
Purpose of the Study:
- To review the biological role of EVs in intercellular communication.
- To summarize advancements in loading EVs for nucleic acid therapy delivery.
- To discuss the potential of EVs as delivery vectors for genetic disorders.
Main Methods:
- Literature review of current research on extracellular vesicles.
- Analysis of methods for loading nucleic acids into EVs.
- Evaluation of EV engineering for targeted delivery.
Main Results:
- EVs possess low immunogenicity, high bioavailability, and inherent targeting capabilities.
- Various methods exist for loading EVs with nucleic acids, each with challenges.
- Engineered EVs show promise for enhanced therapeutic delivery.
Conclusions:
- Extracellular vesicles are versatile natural nanocarriers for nucleic acid therapies.
- Further research is needed to optimize EV loading and targeting strategies.
- EVs hold significant potential for treating genetic disorders.
Related Concept Videos
01:36Overview of Exosomes
3.0K
Exosomes are stable, lipid bilayer-enclosed vesicles capable of crossing biological barriers. They can carry a wide range of molecules required for intercellular communication. Once exosomes are released from the cell where they originated, they enter a recipient cell through various pathways such as fusion, receptor-mediated endocytosis, macropinocytosis, and phagocytosis.
Stahl et al. discovered exosomes in 1983, but the exosomes were initially considered waste products released from the...
Stahl et al. discovered exosomes in 1983, but the exosomes were initially considered waste products released from the...
3.0K
01:29Microorganisms in Medicine and Therapeutics
517
Microorganisms play a fundamental role in vaccine development, gene therapy, and therapeutic production. Their biological properties are harnessed to advance medicine and public health. Beyond immunization, microorganisms contribute to gut health, antibiotic synthesis, and genetic disease treatment.Live Attenuated and Inactivated VaccinesLive attenuated vaccines, such as the measles, mumps, and rubella (MMR) vaccine, utilize weakened forms of pathogens to closely resemble natural infections.
517